The Rising Era of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes

The Rising Era of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases characterized by ineffective hematopoiesis and a wide spectrum of manifestations ranging from indolent and asymptomatic cytopenias to acute myeloid leukemia (AML). MDS result from genetic and epigenetic derangements in clonal cell...

Full description

Saved in:
Bibliographic Details
Main Authors: Nora Chokr, Rima Patel, Kapil Wattamwar, Samer Chokr
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2018/2458679
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items